Candel Therapeutics Stock Widgets and Gadgets
| CADL Stock | USD 4.84 0.20 3.97% |
| Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- CADL Candel Therapeutics
- Latest Acquisition by Tak Paul Peter of 12900 shares of Candel Therapeutics at 1.55 subject to Rule 16b-3
- CADL 4.84 -0.2
- Low 4.83
- High 5.31
- Volume 862.1 K
- Alpha -0.21
- Beta 1.9
- Return On Equity -4.81
- Return On Asset -0.52
- Current Valuation 163.14 M
- Shares Outstanding 32.48 M
- Shares Owned By Insiders 30.39 %
- Shares Owned By Institutions 22.53 %
- Number Of Shares Shorted 1.78 M
- Price To Book 30.41 X
- Price To Sales 436.42 X
- Revenue 31 K
- Gross Profit (20.66 M)
- EBITDA (37.43 M)
- Net Income (37.94 M)
- Cash And Equivalents 86.78 M
- Cash Per Share 3.00 X
- Total Debt 22.76 M
- Debt To Equity 0.38 %
- Current Ratio 14.86 X
- Book Value Per Share 0.44 X
- Cash Flow From Operations (34.24 M)
- Short Ratio 7.72 X
- Earnings Per Share (1.73) X
- Target Price 11.0
- Number Of Employees 42
- Beta -0.87
- Market Capitalization 134.29 M
- Total Asset 41.2 M
- Retained Earnings (137.03 M)
- Working Capital 22.61 M
- Net Asset 41.2 M
- Accumulation Distribution 77930.03
- Daily Balance Of Power (0.42)
- Rate Of Daily Change 0.96
- Day Median Price 5.07
- Day Typical Price 4.99
- Price Action Indicator (0.33)
- Period Momentum Indicator (0.20)
- Relative Strength Index 28.62
Market Snapshot Widget Example
DAX Index Germany | 19,405 0.43 | |
Taiwan Weighted Taiwan | 22,948 0.19 | |
PSI 20 Stock Portugal | 6,439 0.47 | |
CROBEX Croatia | 3,124 0.19 | |
Budapest SE Hungary | 79,472 0.1 | |
IDX 30 Jakarta Indonesia | 458.68 2.23 | |
ISEQ 20 Price Ireland | 1,615 0.28 | |
NYSE Comp USA | 20,220 0.48 | |
Tel Aviv 35 Israel | 2,281 0.93 | |
Coreshares Index Tracker South Afric | 1,100 0.09 | |
IPC MEXICO Mexico | 50,228 0.42 | |
KL Technology Malaysia | 60.32 1.96 | |
IBEX 35 Index Spain | 11,712 0.47 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,543 0.29 | |
SPASX Dividend Opportunities Australia | 1,697 0.26 | |
HNX 30 Vietnam | 471.74 0.81 | |
Bucharest BET-NG Romania | 1,213 0.53 | |
AMS Small Cap Netherlands | 1,188 0.40 | |
Oslo Exchange Mutual Norway | 1,426 0.25 | |
BEL Small Belgium | 8,148 0.53 | |
Basic Materials Brazil | 5,781 0.32 | |
Swiss Leader Price Switzerland | 1,933 0.06 | |
Fondo Mutuo ETF Chile | 1,368 0.41 | |
Athens General Comp Greece | 1,406 0.33 | |
Stock Exchange Of Thailand | 1,443 0.21 | |
PX Prague Stock Czech Repub | 1,697 0.37 | |
THE PHILIPPINE STOCK Philippines | 6,850 1.03 | |
WIG 30 Poland | 2,826 0.44 | |
BIST Electricity Turkey | 493.66 0.85 |
Investing Ideas
In addition to having Candel Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Candel Therapeutics
Compare Candel Therapeutics To Peers
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Candel Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. For more information on how to buy Candel Stock please use our How to buy in Candel Stock guide.You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Candel Therapeutics. If investors know Candel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Candel Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.73) | Revenue Per Share 0.001 | Return On Assets (0.52) | Return On Equity (4.81) |
The market value of Candel Therapeutics is measured differently than its book value, which is the value of Candel that is recorded on the company's balance sheet. Investors also form their own opinion of Candel Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Candel Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Candel Therapeutics' market value can be influenced by many factors that don't directly affect Candel Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Candel Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Candel Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Candel Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.